- Report
- January 2024
- 143 Pages
Global
From €4109EUR$4,250USD£3,529GBP
The Mirena market is a subset of the Sexual and Reproductive Health Drugs market. It is a long-acting, reversible contraceptive device that is inserted into the uterus to prevent pregnancy. It is a hormone-releasing system that releases a progestin hormone, levonorgestrel, to prevent ovulation and thicken cervical mucus. It is a popular form of contraception due to its convenience and effectiveness.
The Mirena market is highly competitive, with many companies offering similar products. Some of the major players in the market include Bayer AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Allergan plc, and Pfizer Inc. Show Less Read more